Lupin Share Price Falls 3.86 Percent, Its Steepest Drop in 10 Weeks

Lupin share price Rs 2,417.30, down 3.86 percent, steepest fall in 10 weeks. Volume down 91.57 percent versus 5 day average. Still 31.47 percent above 52W low.

Updated: 22 Jul 2026 • 12:46 pm

Posted by:

Lupin Share Price Falls 3.86 Percent, Its Steepest Drop in 10 Weeks

The Lupin share price declined sharply on Wednesday, marking its steepest single day fall in 10 weeks. Lupin was quoting at Rs 2,417.30, down Rs 97.10 or 3.86 percent, reversing a chunk of the previous session’s gain of 1.46 percent.

Click Here – Get Free Investment Predictions

Table of Contents

Lupin Share Price: Key Trading Data

Metric	Value
Lupin CMP	Rs 2,417.30
Day Change	Down Rs 97.10 or 3.86 percent
Intraday Range	Rs 2,417.00 to Rs 2,498.90
Volume Today	10,495 shares
5 Day Average Volume	124,519 shares (down 91.57 percent)
Market Capitalisation	Rs 110,527.39 crore

Learn More About Univest, a SEBI Registered Investment Advisor

In the previous trading session, the stock had closed up 1.46 percent, or Rs 36.10, at Rs 2,514.40, meaning today’s decline has erased more than the prior day’s gain. Lupin touched a 52 week high of Rs 2,530.00 on 16 July 2026, just days before today’s fall, and a 52 week low of Rs 1,838.65 on 6 August 2025.

Why Lupin Share Price Fell Sharply Today

The Lupin share price decline comes on a day when the broader Nifty Pharma index and several individual pharma names came under pressure following reports that US President Donald Trump has announced a phased tariff plan targeting imported generic medicines. Given Lupin’s significant exposure to the US generics market, the stock appears to have been caught up in the sector wide reaction to this tariff related headline.

Notably, today’s fall came on unusually thin volume, with trading activity down 91.57 percent compared with the stock’s five day average, a pattern that can sometimes indicate the decline was driven more by a lack of buying support than by heavy directional selling.

Download the Univest iOS App or Univest Android App to track Lupin share price and pharma sector news updates.

Lupin Share Price: What Investors Should Watch

With the Lupin share price still trading 31.47 percent above its 52 week low despite today’s fall, and only 4.45 percent below its recent 52 week high, the stock remains well within its broader uptrend for the year even after this single session setback. Investors should watch whether the pharma sector wide tariff related pressure persists over coming sessions or proves to be a short lived reaction.

Given Lupin’s diversified presence across US generics, branded formulations, complex generics and biosimilars, investors tracking the Lupin share price should assess the company’s specific US commodity generics revenue exposure relative to peers before drawing conclusions about the scale of any potential tariff related earnings impact.

Lupin’s Business Mix and Risk Profile

Lupin has built a diversified pharmaceutical franchise spanning branded and generic formulations across the United States, India, Europe and other emerging markets, alongside a growing complex generics and biosimilars pipeline that carries less commoditised pricing dynamics than standard oral solid generics. This diversification has historically provided some insulation against sector specific shocks concentrated in any single geography or product category.

Nonetheless, the United States remains one of Lupin’s largest markets by revenue contribution, which is why any US policy development affecting generic drug pricing or import costs tends to draw an outsized market reaction in the stock, as seen in today’s session.

Investors should also watch quarterly commentary from Lupin management on pipeline approvals and new product launches in complex generics, since these can provide an offsetting growth lever even during periods of pricing pressure in the base generics business.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did Lupin share price fall today?

Ans. Lupin share price fell 3.86 percent today, its steepest single day drop in 10 weeks, amid a broader pharma sector selloff triggered by reports of a Trump administration tariff plan on imported generic medicines.

What is the current Lupin share price?

Ans. Lupin share price was quoting at Rs 2,417.30, down Rs 97.10 or 3.86 percent, with an intraday high of Rs 2,498.90 and a low of Rs 2,417.00.

What is Lupin’s 52 week high and low?

Ans. Lupin touched a 52 week high of Rs 2,530.00 on 16 July 2026 and a 52 week low of Rs 1,838.65 on 6 August 2025.

How far is Lupin share price from its 52 week high?

Ans. Lupin share price is currently trading 4.45 percent below its 52 week high and 31.47 percent above its 52 week low.

Why was trading volume unusually low during Lupin’s fall today?

Ans. Lupin traded just 10,495 shares today, down 91.57 percent from its five day average of 124,519 shares, suggesting the decline came on thin participation rather than heavy selling volume.

Is Lupin share price a buy after this fall?

Ans. This article does not constitute investment advice. Investors should assess the company’s US generics exposure and consult a SEBI registered investment advisor before investing.